Needham analyst Serge Belanger downgrades Clarus Therapeutics Hldgs (NASDAQ:CRXT) from Buy to Hold.
Piper Sandler Maintains Neutral on Arista Networks, Raises Price Target to $126
Piper Sandler analyst James Fish maintains Arista Networks (NYSE:ANET) with a Neutral and raises the price target from $125 to $126.